Jump to content

Aceperone

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Zppix (talk | contribs) at 00:44, 26 September 2016 (v1.40 - WP:WCW project (Reference before punctuation)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Aceperone
Clinical data
Other namesAcetabuton; R 3248
ATC code
  • none
Identifiers
  • N-({1-[4-(4-Fluorophenyl)-4-oxobutyl]-4-phenyl-4-piperidinyl}methyl)acetamide
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC24H29FN2O2
Molar mass396.498 g/mol g·mol−1
3D model (JSmol)
Melting point97 to 100 °C (207 to 212 °F) [1]
  • Fc1ccc(cc1)C(=O)CCCN3CCC(c2ccccc2)(CC3)CNC(=O)C
  • InChI=1S/C24H29FN2O2/c1-19(28)26-18-24(21-6-3-2-4-7-21)13-16-27(17-14-24)15-5-8-23(29)20-9-11-22(25)12-10-20/h2-4,6-7,9-12H,5,8,13-18H2,1H3,(H,26,28)
  • Key:VDGZERMDPAAZEJ-UHFFFAOYSA-N

Aceperone is a neuroleptic drug of the butyrophenone class. It is an α-noradrenergic blocking drug developed by Janssen Pharmaceutica in the 1960s.[1]

Aceperone has been used as a tool in the study of the biochemical basis of learning. Although aceperone does not block learning per se, it blocks access to an attentional mechanism by which animals ‘tune in’ to the relevant visual dimension when learning a visual discimination task[2][3] at doses below those that affect general behaviour.[4]

References

  1. ^ a b Alkoxylamino and alkoxycarbonylamino derivatives of 1(aroylalkyl)-4-arylpiperidines. Janssen, Paul A. J. (1961) BE 606849 
  2. ^ Ridley, R. M.; Haystead, T. A. J.; Baker, H. F.; Crow, T. J. (1981). "A new approach to the role of noradrenaline in learning: problem-solving in the marmoset after α-noradrenergic receptor blockade". Pharmacology, Biochemistry and Behavior. 14 (6): 849–855. doi:10.1016/0091-3057(81)90373-7.
  3. ^ Baker, H.F.; Ridley, R.M.; Haystead, T.A.J.; Crow, T.J. (1983). "Further consideration of the learning impairment after aceperone in the marmoset: Effects of the drug on shape and colour discrimination and on an alternation task". Pharmacology Biochemistry and Behavior. 18 (5): 701. doi:10.1016/0091-3057(83)90009-6.
  4. ^ Scraggs, P. R.; Ridley, R. M. (1979). "The effect of dopamine and noradrenaline blockade on amphetamine-induced behaviour in the marmoset". Psychopharmacology. 62 (1): 41–5. doi:10.1007/BF00426033. PMID 155838.